Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Care Coordination in Managing Medically Complex Patients
Brief Summary: Patients treated at Veterans Affairs (VA) medical centers are older and have multiple chronic conditions. Two of the most common conditions in the VA population are hypertension (HTN) and Type 2 diabetes (DM). Unfortunately, DM and HTN have few perceptible symptoms on a daily basis that motivate patients to comply with treatment recommendations and lifestyle changes. Thus, serious complications and long-term adverse outcomes are common in both of these conditions.

Home telehealth is a general term used to describe the delivery of health care services to the patient's home using audio, video, or other telecommunications technologies. Although home telehealth offers a number of theoretical advantages, few well-designed controlled clinical trials have been conducted to establish efficacy and cost benefit. Furthermore, projects to date have focused on special populations, e.g., heart failure or mental illnesses. Since home telehealth may hold the most promise for individuals dealing with multiple chronic illnesses, there is a need for population-based studies addressing the needs of patients in primary care settings.

Care coordination, as defined by the VHA Office of Care Coordination, is a process of assessment and ongoing monitoring of patients using home telehealth to proactively enable prevention, investigation, and treatment that enhances the health of patients and prevents unnecessary and inappropriate use of resources. Care coordination embeds technology into a care management process. This results in the right care, at the right time, in the right place.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease | Intervention Type: BEHAVIORAL; Name: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease; Assigned to Arm(s): 2
B: Arm Label: Statin Choice Decision Aid; Type: ACTIVE_COMPARATOR; Interventions: Other: Statin Choice Decision Aid, Other: Usual care for antihyperglycemic medication | Arm Label: Diabetes Medication Choice Decision Aid; Type: ACTIVE_COMPARATOR; Interventions: Other: Diabetes Medication Choice Decision Aid, Other: Usual care for lipid therapy medication | Intervention Type: OTHER; Name: Diabetes Medication Choice Decision Aid; Assigned to Arm(s): Diabetes Medication Choice Decision Aid | Intervention Type: OTHER; Name: Statin Choice Decision Aid; Assigned to Arm(s): Statin Choice Decision Aid | Intervention Type: OTHER; Name: Usual care for lipid therapy medication; Assigned to Arm(s): Diabetes Medication Choice Decision Aid | Intervention Type: OTHER; Name: Usual care for antihyperglycemic medication; Assigned to Arm(s): Statin Choice Decision Aid
C: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Educational Reminder | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Educational Reminder | Intervention Type: BEHAVIORAL; Name: Educational Reminder; Assigned to Arm(s): Control, Intervention
D: Arm Label: Arm 1; Type: OTHER; Interventions: Behavioral: In Home Health Messaging Device | Intervention Type: BEHAVIORAL; Name: In Home Health Messaging Device; Assigned to Arm(s): Arm 1

Answer: D